The latest skin cancer and melanoma news
Early results show that a new combination drug therapy is safe and effective against advanced…
In a new study led by Yale Cancer Center, USA, researchers have advanced a tumour-targeting…
Compared with available standard therapies, including immune checkpoint inhibitors, treatment with the bispecific fusion protein…
On the surface, Parkinson’s disease — a neurodegenerative disorder — and melanoma — a type…
A dysfunctional immune system significantly contributes to the development of cancer. Several therapeutic strategies to…
A personalised tumour cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an…
Among patients at high risk of melanoma, those who received routine skin cancer screening and…
Scientists identify new biomarkers in patients with malignant melanoma, which could help in its diagnosis…
Pre-clinical findings from patient-derived xenograft (PDX) model at Sutter’s California Pacific Medical Center, USA, suggest…
Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than…